Analystreport

ASLAN PHARMACEU/ADR (NASDAQ: ASLN) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating.

ASLAN Pharmaceuticals Limited - American Depositary Shares  (ASLN) 
US:NASDAQ Investor Relations: ir.aslanpharma.com